Week of August 31, 2014

September 3, 2014 ( Wednesday )

Research Meetings
9:00am - 10:00am

"Targeting novel androgen axis resistance mechanisms for development of next generation treatment strategies"

Allen C. Gao, M.D., Ph.D. Ralph de Vere White Professor and Director of Urologic Research UC Davis Cancer Center

Location:  1-5336 SCOTT ROOM

Posted by:  Gwen Stark, Urology, 25-Aug-14 9:42am ET

Other Events & Dates
12:00pm - 1:00pm
Chemistry Ph.D. Defense

Title: Size-Programmed Synthesis of Lead Selenide Quantum Dots

Amanda Preske – University of Rochester, Department of Chemistry Physical Seminar

Location:  Hutchison Hall 473, RC

Posted by:  Marguerite Weston, Chemistry, 26-Aug-14 4:22pm ET

Research Meetings
4:00pm - 5:00pm
The CVRI Seminar Series

The CVRI Seminar Series will resume on September 10, 2014
  View All Dates  

Posted by:  Jacqueline Velazquez, Cardiovascular Research Institute, 20-Jun-14 3:33pm ET

September 4, 2014 ( Thursday )

Research Meetings
12:30pm - 1:30pm
Pharmacology and Physiology Thesis Proposal Seminar

Rafael Gil de Rubio
(Dr. Alan V. Smrcka, Advisor)

"Receptor-stimulated PLC-dependent PI4P Hydrolysis Promoting PKD Activation and Mitogenic Signaling"

Location:  Anders Room (4-6912)

Posted by:  Sharon Runion, 21-Aug-14 1:59pm ET

September 5, 2014 ( Friday )

Other Events & Dates
10:00am - 11:30am
CRISPR-Cas: Tools and applications for mammalian genome engineering

Presented by: Fei Ann Ran, PhD Post-Doctoral Fellow in the Feng Zhang Lab; Junior Fellow, Harvard Society of Fellows; Eli and Edythe L. Broad Institute of Harvard and MIT

The ability to introduce targeted modifications into genomes and engineer model organisms holds enormous promise for biomedical and technological applications, and has driven the development of tools such as zinc finger nucleases (ZFNs) and transcription activator-like effector nucleases (TALENs). We have harnessed the Cas9 nuclease from the bacterial CRISPR (clustered regularly interspaced short palindromic repeats) adaptive immune system for targeted editing of the mammalian genome. Cas9 can be easily programmed by short guide RNAs to induce gene knockout or homology-directed repair with robust efficiency and is highly amenable to multiplexed applications. In addition, we have also engineered a Cas9 nicking mutant and devised a "double nicking" strategy to facilitate high-precision genome editing with minimal off-target mutagenic activity, enabling applications across basic science, biotechnology, and medicine. The seminar will also discuss the newest developments in using Cas9 for in vivo and therapeutic applications.

Location:  Class of '62 Auditorium, G-9425

Posted by:  Anne Reed, Shared Resource Laboratories, 2-Sep-14 11:28am ET